Leveraging state-of-the-art mass spectrometry, our untargeted discovery proteomics method achieves high analytical specificity while optimizing for protein coverage and throughput to best suit your bioanalytical needs.
Our mass spectrometry approach annotates proteins and post-translational modifications (PTMs) via direct peptide sequencing. Peptide-level information enables precise protein identification, and capture of PTMs allows for more in-depth analysis of protein function and regulation.
The additional value is that Sapient’s discovery proteomics services are scalable. Choose the coverage depth and throughput that aligns with your specific study objectives.
Download the fact sheet to explore our specialized approaches, including Sapient’s /HT/ Discovery, /Core/ Discovery, and /Deep/ Discovery proteomics, and how we can also provide integrative multi-omics data analyses to amplify insights for your study.
Our data science team can combine proteomics data with metabolomics, lipidomics, and genomics data as well as preclinical and clinical inputs to elucidate protein biomarkers and their involvement in the dynamic processes underlying disease and drug response.